Nasus Pharma Ltd. (AMEX: NSRX) last traded at $3.20, down 3.61% on the session. The quote above updates while this page is open; the figures below are drawn from Nasus Pharma Ltd.’s own filings and are restated only when a new one is published.
Nasus Pharma Ltd. trades on AMEX under the ticker NSRX. Its market capitalisation is $28.85 million.
Valuation measures for Nasus Pharma Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $28.85M |
|---|---|
| Enterprise value | $29.85M |
| Price / sales | 0.02 |
| Price / book | 10.42 |
| Beta | 0.87 |
Trailing-twelve-month figures tagged in Nasus Pharma Ltd.'s XBRL filings with the SEC.
| Revenue (TTM) | $1.24B |
|---|
| Net income (TTM) | -$5.86M |
|---|
| EPS (TTM) | -$0.720 |
|---|
| Operating margin | -0.40% |
|---|
| Return on equity | -211.56% |
|---|
| Cash | $1.24M |
|---|
Range and volume for NSRX over the past 52 weeks.
| 52-week high | $9.50 |
|---|---|
| 52-week low | $1.98 |
| Volume | 10.7K |
| Average volume | 16.1K |
| Previous close | $3.32 |
Invest a chosen dollar amount in Nasus Pharma Ltd. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NSRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.